Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
FEBS Lett ; 588(24): 4665-71, 2014 Dec 20.
Article in English | MEDLINE | ID: mdl-25447521

ABSTRACT

The mouse delta-like homolog 1 and type III iodothyronine deiodinase (Dlk1-Dio3) imprinted domain contains three known paternally methylated differentially methylated regions (DMRs): intergenic DMR (IG-DMR), maternally expressed 3-DMR (Gtl2-DMR), and Dlk1-DMR. Here, we report the first maternally methylated DMR, CpG island 2 (CGI-2), is located approximately 800 bp downstream of miR-1188. CGI-2 is highly methylated in sperm and oocytes, de-methylated in pre-implantation embryos, and differentially re-methylated during post-implantation development. CGI-2, similarly to Gtl2-DMR and Dlk1-DMR, acquires differential methylation prior to embryonic day 7.5 (E7.5). Both H3K4me3 and H3K9me3 histone modifications are enriched at CGI-2. Furthermore, CCCTC-binding factor (CTCF) binds to both alleles of CGI-2 in vivo. These results contribute to the investigation of imprinting regulation in this domain.


Subject(s)
DNA Methylation , Genomic Imprinting , Intercellular Signaling Peptides and Proteins/genetics , Iodide Peroxidase/genetics , Mothers , Animals , Base Sequence , CCCTC-Binding Factor , Calcium-Binding Proteins , CpG Islands/genetics , Embryo Implantation , Embryonic Development/genetics , Female , Histones/chemistry , Histones/metabolism , Introns/genetics , Mice , MicroRNAs/genetics , Pregnancy , Repressor Proteins/metabolism
2.
Genes Genet Syst ; 88(2): 127-33, 2013.
Article in English | MEDLINE | ID: mdl-23832304

ABSTRACT

The Dlk1-Dio3 imprinted domain on mouse chromosome 12qF1 contains three paternally expressed protein-coding genes and multiple maternally expressed long or short noncoding RNA genes. All these imprinted genes are regulated by IG-DMR located between Dlk1 and Meg3/Gtl2. Recently, several novel imprinted noncoding RNAs were identified in the intergenic region of this domain, although the exact number of imprinted genes within the region is unclear. Here, we report that a novel noncoding RNA, AK003491, located between Meg3/Gtl2 and Meg8, is maternally expressed in E15.5 brain, tongue, heart, lung, liver and kidney tissues. In situ hybridization analysis at E15.5 shows AK003491 is predominantly expressed in forebrain, tongue, thymus, somites, lung and liver. Quantitative real-time RT-PCR analysis confirms this expression pattern and detects highest expression in tongue. While the AK003491 expression pattern at postnatal day 1 is similar to E15.5, AK003491 expression at postnatal day 30 is mainly restricted to the brain. These results expand the number of known imprinted long noncoding RNAs in this domain, and contribute to further investigation of their regulatory mechanism and function.


Subject(s)
Brain/metabolism , Embryo, Mammalian/cytology , Gene Expression Regulation, Developmental , Genomic Imprinting , RNA, Untranslated/genetics , Tongue/metabolism , Animals , Embryo, Mammalian/metabolism , Female , In Situ Hybridization , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , RNA, Messenger/genetics , RNA, Untranslated/metabolism , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
3.
Genes Genet Syst ; 87(1): 53-8, 2012.
Article in English | MEDLINE | ID: mdl-22531794

ABSTRACT

Imprinted genes have important effects on the regulation of fetal growth, development, and postnatal behavior. However, the study of imprinted genes has been limited in mammalian species other than human and mouse. Therefore, the study of porcine imprinted genes is useful for defining the extent of conservation of genomic imprinting among different species. In this study, the imprinting status of porcine NDN, MAGEL2 and MEST genes was determined by direct sequencing of the cDNAs and detection of single nucleotide polymorphisms (SNPs) identified in individuals from reciprocal crosses between Meishan and Large White pigs for allele discrimination. The analysis was carried out in 13 different tissues (skeletal muscle, fat, pituitary gland, heart, lung, liver, kidney, spleen, stomach, small intestine, uterus, ovary and testis) from 12 two-month-old piglets. Imprinting analysis showed that NDN and MAGEL2 were paternally expressed in all tissues where the genes were expressed as in human and mouse. Interestingly, MEST showed tissue-specific imprinting, being paternally expressed in skeletal muscle, fat, pituitary gland, heart, kidney, lung, stomach and uterus, and maternally expressed in spleen and liver.


Subject(s)
Antigens, Neoplasm/genetics , Genomic Imprinting , Nerve Tissue Proteins/genetics , Nuclear Proteins/genetics , Proteins/genetics , Sus scrofa/genetics , Animals , Antigens, Neoplasm/metabolism , Base Sequence , Female , Gene Expression Profiling , Hybridization, Genetic , Male , Molecular Sequence Data , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Organ Specificity , Polymorphism, Single Nucleotide , Proteins/metabolism , Real-Time Polymerase Chain Reaction , Sequence Analysis, DNA , Transcription, Genetic
4.
J Mol Histol ; 42(4): 333-9, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21706278

ABSTRACT

The Dlk1-Dio3 imprinted domain not only is implicated growth and development of the embryo and placenta, but also affects adult metabolism and brain function. In this study, we identified the imprinting status of a mouse non-coding RNA gene, B830012L14Rik, mapped to the Dlk1-Dio3 domain by the polymorphism- and sequencing-based approach. Imprinting analysis showed that the gene was expressed maternally at E15.5, E18.5 and postnatal day 1 mice. Two transcripts of approximately 1.9 and 3.5 kb were detected by northern blot. Furthermore, we examined the spatiotemporal expression patterns of the gene during the mouse development. In situ hybridization analysis showed that B830012L14Rik was mainly expressed in forebrain, pituitary, cartilage primordium of spinal column, lung and liver at E13.5 and E15.5. The results of real-time quantitative RT-PCR showed that the B830012L14Rik expression in brain, heart, lung and liver was higher at E15.5 than at E12.5 and E18.5. Furthermore, the gene expression increased progressively in brain from E12.5 to E15.5 whereas decreased from E15.5 to E19.5. This study may provide further insights into the imprinting, genomic features and expression regulation of the Dlk1-Dio3 imprinted cluster.


Subject(s)
Genomic Imprinting/genetics , Intercellular Signaling Peptides and Proteins/genetics , Iodide Peroxidase/genetics , RNA, Untranslated/genetics , Animals , Base Sequence , Calcium-Binding Proteins , Embryo, Mammalian/cytology , Embryo, Mammalian/metabolism , Female , Gene Expression Profiling , Gene Expression Regulation , Gene Order , Male , Mice , Mice, Inbred C57BL , Mice, Inbred ICR , Polymorphism, Single Nucleotide/genetics , Transcription, Genetic
5.
Genes Genet Syst ; 86(1): 47-52, 2011.
Article in English | MEDLINE | ID: mdl-21498922

ABSTRACT

Imprinted genes are expressed monoallelically depending on their parental origin, and play important roles in the regulation of fetal growth, development, and postnatal behavior. Most genes known to be imprinted have been identified and studied in the human and the mouse. However, there are only a small number of reported imprinted genes in pigs. Therefore, identification and characterization of more imprinted genes in pigs is useful for comparative analysis of genomic imprinting across species. In this study, we cloned the porcine PEG3, NAP1L5 and PPP1R9A genes. The imprinting status of these genes was determined using sequencing directly and single nucleotide polymorphisms (SNPs) identified in individuals from reciprocal cross of Meishan and Large White pigs. Imprinting analysis was carried out in 13 different tissues (skeletal muscle, fat, pituitary gland, heart, lung, liver, kidney, spleen, stomach, small intestine, uterus, ovary and testis) from twelve 2-month-old piglets. Imprinting analysis showed that PEG3 and NAP1L5 were exclusively expressed from the paternal allele whereas PPP1R9A was biallelically expressed in all tissues tested where the genes were expressed. The study is of interest to understand the conservation of genomic imprinting among mammals at the 3 loci.


Subject(s)
Genomic Imprinting/genetics , Kruppel-Like Transcription Factors/genetics , Microfilament Proteins/genetics , Nerve Tissue Proteins/genetics , Nucleosome Assembly Protein 1/genetics , RNA, Messenger/metabolism , Swine/genetics , Animals , Base Sequence , Crosses, Genetic , DNA Primers/genetics , DNA, Complementary/genetics , Kruppel-Like Transcription Factors/metabolism , Microfilament Proteins/metabolism , Molecular Sequence Data , Nerve Tissue Proteins/metabolism , Nucleosome Assembly Protein 1/metabolism , Polymorphism, Single Nucleotide/genetics , RNA, Messenger/genetics , Sequence Analysis, DNA , Swine/metabolism
6.
Mol Cell Biochem ; 351(1-2): 109-16, 2011 May.
Article in English | MEDLINE | ID: mdl-21246261

ABSTRACT

Tumor development has long been known to resemble abnormal embryogenesis. The ESC self-renewal gene NANOG is purportedly expressed in some epithelial cancer cells and solid tumors, but a casual role in tumor development has remained unclear. In order to more comprehensively elucidate the relationship between human Nanog and tumorigenesis, the hNanog was ectopically expressed in the 293 cell line to investigate its potential for malignant transformation of cells both in vitro and in vivo. Here we provide compelling evidence that the overexpression of hNanog resulted in increased cell proliferation, anchor-independent growth in soft agar, and formation of tumors after subcutaneous injection of athymic nude mice. Pathologic analysis revealed that these tumors were poorly differentiated. In analysis of the underlying molecular mechanism, two proteins, FAK and Ezrin, were identified to be upregulated in the hNanog expressing 293 cells. Our results demonstrate that hNanog is a potent human oncogene and has the ability to induce cellular transformation of human cells.


Subject(s)
Cell Transformation, Neoplastic/genetics , Homeodomain Proteins/genetics , Animals , Cell Line , Cytoskeletal Proteins/metabolism , Electrophoresis, Gel, Two-Dimensional , Focal Adhesion Protein-Tyrosine Kinases/metabolism , Humans , Mice , Mice, Nude , Nanog Homeobox Protein , Oncogenes , Up-Regulation
7.
Sheng Wu Gong Cheng Xue Bao ; 23(2): 195-200, 2007 Mar.
Article in Chinese | MEDLINE | ID: mdl-17460887

ABSTRACT

Adipose tissue contains a population of multipotent cells called adipose-derived stem cells (ADSCs). With the similar properties of marrow-derived mesenchymal stem cells, ADSCs have the ability to differentiate differentiate towards adipogenic, osteogenic, chondrogenic, myogenic, endothelial, hematopoietic, hepatic, islet, and neurogenic cell lineages. As adipose tissue in harvested in large amounts with minimal morbidity, it can be widely used in tissue engineering, organ repair and gene therapy. This paper focused on the plasticity of ADSCs and reviewed the new advances of this field. Finally, the problems and prospect for application was also discussed.


Subject(s)
Adipose Tissue/cytology , Cell Differentiation , Multipotent Stem Cells/cytology , Stem Cells/cytology , Adipose Tissue/metabolism , Animals , Antigens, CD/metabolism , Cell Culture Techniques , Genetic Therapy , Humans , Multipotent Stem Cells/metabolism , Stem Cells/metabolism , Tissue Engineering
8.
Cell Tissue Res ; 327(1): 55-66, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16951941

ABSTRACT

An efficient co-culture system, especially with oviductal or uterine epithelial cells, is important not only for the production of high quality embryos, but also for the study of the molecular dialogue between embryos and their maternal environment. Although mouse embryos have been co-cultured successfully with oviductal epithelial cells (OECs) from several species, studies on the effects of species and functionality of OECs are few. Reports concerning the necessity of direct contact between the embryo and OECs and about the culture of mouse embryos in medium conditioned with heterologous OECs have been controversial. In this study, pronuclear embryos from Kunming mice, characterized by an obvious two-cell block in vitro, were co-cultured with mouse, goat, and chick OECs. The functionality of OECs was determined by analyzing the cell cycle, apoptosis, the numbers of mitochondria and cilia, and the ability both to support embryonic development and to remove hypoxanthine from the culture medium. The necessity of direct contact between OECs and embryos was studied by repeated renewal of culture medium with fresh conditioned medium, the culture of embryos in plastic wells connected by tunnels to wells with OEC monolayers, and the co-culture of embryos separated from OECs by a filter. Both goat and chick OECs supported mouse embryonic development, but their embryotrophic lifespan was shorter than that of the mouse OECs. Whereas media conditioned with mouse OECs supported mouse embryonic development satisfactorily, medium conditioned with goat OECs supported little development. Immediate dialogue between heterologous OECs and embryos was essential for efficient co-culture, whereas direct contact between the two cell types was not; neither dialogue nor contact was needed between isologous OECs and embryos. Embryotrophic activity and the ability to remove hypoxanthine from conditioned medium declined with time after confluence and number of passages of OECs, mainly because of apoptosis and dedifferentiation. Thus, the species and functionality of OECs have profound effects on their molecular dialogue with co-cultured embryos, and efficient co-culture depends upon both positive and negative conditioning.


Subject(s)
Embryo, Mammalian/cytology , Embryonic Development/physiology , Epithelial Cells/cytology , Oviducts/cytology , Animals , Apoptosis/drug effects , Cell Communication/drug effects , Cell Count , Coculture Techniques , Culture Media, Conditioned/pharmacology , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , Embryonic Development/drug effects , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Female , Goats , Mice , Microscopy, Confocal , Mitochondria/ultrastructure , Oviducts/drug effects , Oviducts/metabolism , Species Specificity
9.
Reproduction ; 132(5): 749-58, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17071776

ABSTRACT

Using a well-in-drop (WID) oocyte/embryo culture system that allows identification of follicular origin, we have investigated the effects of granulosa cells (GCs) apoptosis, follicle size, cumulus-oocyte complexes (COCs) morphology, and cumulus expansion on the developmental competence of goat oocytes matured and cultured individually following parthenogenetic activation. The WID system supported oocyte maturation and embryo development to a level similar to the conventional group system. The majority of goat oocytes acquired competence for development up to the 8-16 cell stage in follicles larger than 2 mm, but did not gain the ability to form morula/blastocyst (M/Bs) until follicles larger than 3 mm in diameter. The extent of atresia affected M/Bs formation. This effect varied according to the follicle size. Cumulus expansion increased with follicle size and decreased with increasing incidence of GCs apoptosis. Oocyte developmental potential was also correlated with cumulus expansion. Regardless of the degree of follicle atresia, 73-84% of the floating cells in the follicular fluid (FF) underwent apoptosis. Correlation between floating cell density in FF and oocyte developmental potency suggests the possibility to use the floating cell density as a simple and non-invasive marker for oocyte quality. It is concluded that the developmental potential of an oocyte is determined by multifactor interactions, and multiple factors must be considered together to accurately predict the quality of an oocyte.


Subject(s)
Goats/physiology , Granulosa Cells/cytology , Oocytes/cytology , Ovarian Follicle/anatomy & histology , Animals , Apoptosis , Coculture Techniques/methods , Embryonic Development , Female , Follicular Fluid/physiology , Parthenogenesis
10.
Mol Reprod Dev ; 73(7): 834-40, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16572465

ABSTRACT

Dairy goats are ideal for the transgenic production of therapeutic recombinant proteins. The use of recombinant somatic cell lines for nuclear transfer (NT) allows the introduction of genes by transfection, increases the efficiency of transgenic animal production to 100%, and overcomes the problem of founder mosaicism. Although viable animals have been cloned via NT from somatic cells of 11 species, the efficiency has been extremely low. Both blastomere and somatic cell NT increased fetal loss and perinatal morbidity/mortality in cattle and sheep, but fetal loss and perinatal mortality appear to be relatively low in goats. In this study, we produced cloned goats by NT from cumulus cells and long-term cultured fetal fibroblast cells (FFCs) to abattoir-derived oocytes. NT embryos were constructed from electrofusion of cumulus cells (CCs), FFCs, or skin fibroblast cells (SFCs) with cytoplasts prepared from abattoir-derived ovaries. The NT embryos were activated with an optimized activating protocol (1 min exposure to 2.5 microM ionomycin followed by 2 hr incubation in 2mM 6-DMAP). Two viable cloned kids from CCs and one from long-term cultured FFCs (at passage 20-25) were born. Microsatellite analysis of 10 markers confirmed that all cloned offspring were derived from corresponding donor cells. To our knowledge, the production of cloned goat offspring using abattoir-derived oocytes receiving nuclei from CCs and long-term cultured FFCs has not been reported. The production of viable cloned animals after activation with reduced intensity of ionomycin and 6-DMAP treatment has also not been reported. Loss of cloned embryos was obvious after 45 and 90 days of pregnancy, and a lack of cotyledons, heart defects, and improperly closed abdominal wall were observed in the aborted fetuses and one cloned kid. The fusibility and in vitro developmental potential of embryos reconstructed from FFCs at passage 20-25 were significantly lower than those of embryos reconstructed from FFCs at passage 3-5, and the cloning efficiency of the long-term cultured cells was low (0.5%).


Subject(s)
Cloning, Organism/methods , Embryo Transfer , Goats , Oocytes , Abattoirs , Abortion, Veterinary , Animals , Cells, Cultured , Embryonic Development , Female , Fibroblasts/cytology , Goat Diseases , Goats/genetics , Nuclear Transfer Techniques , Oocytes/cytology , Ovarian Follicle/cytology , Pregnancy
11.
Mol Reprod Dev ; 73(2): 238-46, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16250008

ABSTRACT

Goat oocytes from 2 to 4 and 0.8 to 1.2-mm follicles were freed (DOs) or not (COCs) of cumulus cells and cultured for different times in an inhibition medium supplemented with different concentrations of roscovitine (ROS). At the end of culture, oocytes were either cultured in a maturation medium for 24 hr and activated chemically for embryo development, or examined for GV chromatin configurations. Nuclear status was checked at different time points during maturation culture. Although both 200 and 250 microM ROS maintained 78-85% of oocytes at the GV stage for 24 hr, only oocytes blocked with 200 microM ROS developed to MII stage at a high rate after maturation culture. While few oocytes blocked with 200 microM ROS for 24 hr developed into morulae and none into blastocysts after activation, percentages of oocytes developing into morulae and blastocysts increased to the level of the control oocytes when the block time was reduced to 8 hr. While the GV and pMI stages were shortened with MI, and A/TI unaffected after oocytes were blocked for 8 hr, all the stages but A/TI were shortened after 24 hr of block. The sizes of nucleoli diminished with time and the GV chromatin configuration changed during ROS block. Significantly more DOs than COCs were blocked with 200 microM ROS, but none of the blocked DOs matured after drug withdrawal. However, maturation of the DOs improved significantly when ROS concentration was reduced to 150 microM or DOs were co-inhibited with COCs. The GV intact percentages of DOs did not differ after ROS inhibition with or without eCG, but those of COCs decreased significantly after ROS inhibited in the presence of eCG. When MII-incompetent oocytes from 0.8 to 1.2-mm follicles were inhibited with ROS for 8 and 24 hr prior to maturation culture, nuclear maturation improved significantly, activation rates were as high as that of the control oocytes, and some of the activated developed to 4- or 8-cell stages. It is concluded that (i) the efficiency and reversibility of ROS block was both drug concentration and exposure-time dependent; (ii) cumulus cells alleviated the toxicity of ROS on goat oocytes; (iii) eCG released goat oocytes from ROS block through the mediation of cumulus cells; (iv) ROS block quickened the nuclear maturation of goat oocytes and improved the developmental competence of meiosis-incompetent oocytes, possibly due to a sustained nuclear activity during inhibition culture; (v) oocyte nuclear maturation and activation did not depend upon cumulus expansion, but the embryo development occurred in association with cumulus expansion.


Subject(s)
Meiosis/physiology , Oocytes/drug effects , Oocytes/physiology , Purines/pharmacology , Animals , Cells, Cultured , Chromatin/metabolism , Culture Media/chemistry , Dose-Response Relationship, Drug , Female , Goats , Meiosis/drug effects , Oocytes/cytology , Ovarian Follicle/metabolism , Roscovitine , Time Factors
12.
Theriogenology ; 64(5): 1142-57, 2005 Sep 15.
Article in English | MEDLINE | ID: mdl-16125558

ABSTRACT

Strontium has been successfully used to induce activation of mouse oocytes in nuclear transfer and other experiments, but the optimum treatment conditions have not been studied systematically. When cumulus-free oocytes were treated with 10mM SrCl(2) for 0.5-5h, activation rates (88.4+/-4.1 to 91.2+/-2.7%) did not differ (mean+/-S.E.; P>0.2), but rate of blastulation (57.3+/-3.5%) and cell number per blastocyst (45.0+/-2.4) were the highest after treatment for 2.5h. When treated with 1-20mM SrCl(2) for 2.5h, the activation rate and cell number per blastocyst were higher (P<0.02) after 10mM SrCl(2) treatment than other treatments. The best activation and development were obtained with Ca(2+)-free Sr(2+) medium, but the activation rate was low (37.7+/-1.6%) in Ca(2+)-containing medium. Activation rates were the same, regardless of the presence or absence of cytochalasin B (CB) in the activating medium, but the blastulation rate was higher (P<0.001) in the presence of CB. Only 70% of the cumulus-enclosed oocytes were activated and 10% blastulated after a 10 min exposure to 1.6mM SrCl(2), and many lysed, with increased intensity of Sr(2+) treatment. The presence of CB in SrCl(2) medium markedly reduced lysis of cumulus-enclosed oocytes. Media M16 and CZB did not differ when used as activating media. Only 10.5% of the oocytes collected 13 h post hCG were activated by Sr(2+) treatment alone, with 34% blastulating, but rates of activation and blastulation increased (P<0.001) to 94 and 60%, respectively, when they were further treated with 6-dimethylaminopurine (6-DMAP). The total and ICM cell numbers were less (P<0.001) in parthenotes than in the in vivo fertilized embryos. In conclusion, the concentration and duration of SrCl(2) treatment and the presence or absence of CB in activating medium and cumulus cells had marked effects on mouse oocyte activation and development. To obtain the best activation and development, cumulus-free oocytes collected 18 h post hCG should be treated for 2.5h with 10mM SrCl(2) in Ca(2+)-free medium supplemented with 5 microg/mL of CB.


Subject(s)
Oocytes/physiology , Parthenogenesis/drug effects , Strontium/pharmacology , Adenine/administration & dosage , Adenine/analogs & derivatives , Animals , Blastocyst/cytology , Calcium/pharmacology , Cell Count , Culture Media , Cytochalasin B/pharmacology , Dose-Response Relationship, Drug , Embryo Culture Techniques , Female , Intracellular Signaling Peptides and Proteins/pharmacology , Magnesium/pharmacology , Mice , Oocytes/drug effects
13.
Mol Reprod Dev ; 71(3): 380-8, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15806561

ABSTRACT

The protocol of ionomycin followed by 6-dimethylaminopurine (6-DMAP) is commonly used for activation of oocytes and reconstituted embryos. Since numerous abnormalities and impaired development were observed when oocytes were activated with 6-DMAP, this protocol needs optimization. Effects of concentration and treatment duration of both drugs on activation and development of goat oocytes were examined in this study. The best oocyte activation (87-95%), assessed by pronuclear formation, was obtained when oocytes matured in vitro for 27 hr were treated with 0.625-20 microM ionomycin for 1 min before 6-hr incubation in 2 mM 6-DMAP. Progressional reduction of time for 6-DMAP-exposure showed that the duration of 6-DMAP treatment can be reduced to 1 hr from the second up to the fourth hour after ionomycin, to produce activation rates greater than 85%. Activation rates of oocytes in vitro matured for 27, 30, and 33 hr were higher (P < 0.05) than that of oocytes matured for 24 hr when treated with ionomycin plus 1-hr (the third hour) 6-DMAP, but a 4-hr incubation in 6-DMAP enhanced activation of the 24-hr oocytes. Goat activated oocytes began pronuclear formation at 3 hr and completed it by 5-hr post ionomycin. An extended incubation in 6-DMAP (a) impaired the development of goat parthenotes, (b) quickened both the release from metaphase arrest and the pronuclear formation, and (c) inhibited the chromosome movement at anaphase II (A-II) and telophase II (T-II), leading to the formation of one pronucleus without extrusion of PB2. In conclusion, duration, concentration, and timing of ionomycin and 6-DMAP treatment had marked effects on goat oocyte activation, and to obtain better activation and development, goat oocytes matured in vitro for 27 hr should be activated by 1 min exposure to 2.5 microM ionomycin followed by 2 mM 6-DMAP treatment for the third hour.


Subject(s)
Adenine/analogs & derivatives , Ionomycin/pharmacology , Ionophores/pharmacology , Meiosis/drug effects , Oocytes/physiology , Protein Kinase Inhibitors/pharmacology , Animals , Cells, Cultured , Female , Goats , Oocytes/cytology
14.
Cell Res ; 14(4): 341-6, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15353131

ABSTRACT

It is well known that during mammalian ovarian follicular development, the majority of follicles undergo atresia at various stages of their development. However, the mechanisms controlling this selection process remain unknown. In this study, we investigated apoptosis in granulosa cells during goat follicular atresia by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). The changes in the levels of steroids, insulin-like growth factors (IGFs) and IGF receptors were studied by radioimmunoassay (RIA) and semi-quantitative reverse transcription-PCR. We found that the percentage of apoptotic granulosa cells in the atretic (A) follicles was significantly higher than that in the slightly atretic (SA) and healthy (H) follicles. The level of estradiol and the ratio of estradiol to progesterone in H follicles were significantly higher than those in A follicles. On the other hand, the level of progesterone was not significantly different among these follicle types. We also found that the level of IGF-I in H follicles was higher than in SA and A follicles, whereas the amount of IGF-II did not vary significantly. The expression of IGF receptor also decreased in A follicles as compared to that in H and SA follicles. These results suggested that estradiol and IGF-I might be involved in controlling apoptosis in granulosa cells during follicular atresia.


Subject(s)
Apoptosis/physiology , Follicular Atresia/physiology , Granulosa Cells/metabolism , Ovarian Follicle/metabolism , Somatomedins/metabolism , Steroids/metabolism , Animals , Estrogens/metabolism , Female , Follicular Fluid/metabolism , Goats , Granulosa Cells/cytology , In Situ Nick-End Labeling , In Vitro Techniques , Insulin-Like Growth Factor I/metabolism , Insulin-Like Growth Factor II/metabolism , Ovarian Follicle/cytology , Progesterone/metabolism , Radioimmunoassay , Receptor, IGF Type 1/metabolism , Testosterone/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...